News

07/02/2002
Press Release

Isonics Announces Manufacturing Agreement With GlobiTech Industry Leader to Supply Silicon-28 Wafers to GlobiTech Customers
Tuesday July 2, 8:03 am Eastern Time Press Release SOURCE: Isonics Corporation GOLDEN, Colo.--(BUSINESS WIRE)--July 2, 2002--Isonics Corporation (Nasdaq:ISON - News) announced that GlobiTech Incorporated, an epitaxial wafer foundry located in Sherman, Texas, has been qualified to produce silicon-28 epitaxial wafers using silicon-28 trichlorosilane. Isonics has also agreed to work with GlobiTech to supply silicon-28 wafers to certain GlobiTech customers. Dr. Stephen Burden, Isonics' Vice President of Semiconductor Materials, commented, "GlobiTech has a world class epi facility that can meet the requirements for 0.13 micron and below technology, essential to make next generation micrprocessors. Having GlobiTech as a qualified supplier allows Isonics additional flexibility to supply all sizes of silicon-28 wafers to the semiconductor industry." "Silicon-28 provides a synergistic relationship for Isonics, GlobiTech and our customers," said Keith Lindberg, Vice President of GlobiTech. "As Moore's Law begins to run into physical limitations, engineered material solutions are becoming increasingly important. We feel that the improved thermal conductivity of silicon-28 should present unique solutions for advancements in IC performance and reliability." Isotopically purified silicon-28 has 60% higher thermal conductivity than natural silicon and can reduce the self heating of integrated circuits and help solve thermal management problems in a wide range of semiconductor devices presently made with normal silicon wafers. Isonics is a world leader in isotopically engineered materials and produces isotopically pure, high thermal conductivity silicon-28 chemicals and wafers for the semiconductor industry. Isonics also markets and sells stable isotopes for the health care industry such as carbon- 13 for diagnostic breath tests and drug design, and oxygen- 18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Additional information may be obtained at http://www.isonics.com. GlobiTech is a provider of world-class CMOS epitaxial services and epitaxial-based materials solutions for the semiconductor industry. GlobiTech has Class-1 cleanrooms for the production of 150mm and 200mm epitaxial products with 300mm epitaxial samples expected to be available in the fourth quarter of 2002. Ongoing efforts at GlobiTech include application-specific epitaxial solutions for IC performance and reliability improvements, silicon germanium development programs and investigation of epitaxial-based technologies for silicon-on-insulator (SOI) production. Additional information may be obtained at http://www.globitech.com or by contacting Mark England of GlobiTech Marketing and Sales at (903) 957-1904. Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2001, and its quarterly report on Form 10-QSB for the nine months ended January 31, 2002, both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. ------------------------------------------------------------ -------------------- Contact: Isonics Corporation, Golden Dr. Stephen J. Burden, 303/279-7900 sburden@isonics.com or Investor Relations Services, Inc., New Smyrna Beach, FL Nicole Mongelli, 386/409-0200 ison@invrel.net or Globitech, Inc., Sherman, Texas Mark England, 903/957-1904 mengland@globitech.com